drugset / Trial / NCT01773473

Comparison of Insulin Mix25 Versus Mix50

NCT01773473

Phase 4 Completed 403 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the efficacy and safety of insulin Lispro Mix25 (LM25) compared to insulin Lispro Mix50 (LM50) as an insulin starter in participants with Type 2 diabetes mellitus (T2DM).

Timeline

Start
2013-01
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Mix25 Unknown Subcutaneous
Subject Insulin Lispro Mix50 Unknown Subcutaneous